Clinical Trials Browser

Phase 2 × OTHER × Meropenem × Clear all

NCT04983901 2024-11-04

PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN

Phase 2 Completed

100 enrolled 38 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT03485950 2022-03-15

Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam

Phase 2 Completed

100 enrolled 33 charts

Other Infectious Diseases